Ursprung des Netzwerks ersten Grades von Nilesh Modi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.
9
| Subsidiary | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nilesh Modi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Founder Director of Finance/CFO | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
London Pilsner Ltd.
 London Pilsner Ltd. Food DistributorsDistribution Services London Pilsner Ltd. is a full-service drinks and distribution partner that was founded in 1994. The private company is based in London, UK and exports brands to over 21 markets around the world. The British company has an extensive portfolio of own label brands and distributes famous brands worldwide. The company has an unrivaled reach and capability in exporting iconic drinks brands and help brand owners penetrate new and emerging markets. | Food Distributors | Director/Board Member | |
Valiant Holdings Ltd.
 Valiant Holdings Ltd. Regional BanksFinance Valiant Holdings Ltd. is a holding British company that operates subsidiaries engaged in foreign exchange intermediation activities. The private company is based in Middlesex, UK. and has subsidiaries in United Kingdom. The company was founded in 2008. | Regional Banks | Director/Board Member | |
Lexcross Ltd.
 Lexcross Ltd. Miscellaneous Commercial ServicesCommercial Services Lexcross Ltd. is a British management consulting company that provides management consulting services. The private company is based in Northwood Hills, UK and was founded in 2011. | Miscellaneous Commercial Services | Director/Board Member | |
Highassets Ltd.
 Highassets Ltd. Real Estate DevelopmentFinance Founded in 2003, Highassets Ltd. is a British real estate company that engages in buying, selling, and leasing properties. Part of Milebank Ltd., the company is based in Northwood Hills, UK. | Real Estate Development | Director/Board Member | |
T. Bro Investment Ltd.
 T. Bro Investment Ltd. Real Estate DevelopmentFinance T. Bro Investment Ltd. is a British company that engages in letting and operating real estate properties. The private company is based in Middlesex, UK. | Real Estate Development | Director/Board Member | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
| University of California | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
| London Business School | College/University | Masters Business Admin | |
Ambagon Therapeutics, Inc.
 Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer | |
Syri Ltd. (United Kingdom)
 Syri Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Gowrie Holdings Ltd., Syri Ltd. is a British UK-based company founded in 2010. The company specializes in the development, licensing, manufacture, and marketing of liquid medicines. | Pharmaceuticals: Major | Director/Board Member | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CELLTRION HEALTHCARE CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| Seoul National University | College/University | Doctorate Degree | |
| Celltrion Healthcare Japan KK | President | ||
Cellemedy Co., Ltd.
 Cellemedy Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Cellemedy Co., Ltd. develops next-generation cancer treatments to improve the health of people suffering from cancer. The company is based in Seongnam-si, South Korea. The South Korean company was founded in 2016. The CEO is Ha-Chul Kim. | Miscellaneous Commercial Services | President | |
| Novelgen Co. Ltd(South Korea) | Director/Board Member | ||
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| The University of Chicago Law School | College/University | Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
| PERELLA WEINBERG PARTNERS | Investment Banks/Brokers | Corporate Officer/Principal | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
Spread Co Ltd.
 Spread Co Ltd. Financial ConglomeratesFinance Spread Co Ltd. is a British broker founded in 2006 that offers spread betting, CFDs, FOREX, and other financial services. The private company is based in London, UK. The British company's trading platform includes pro charting at no extra cost. | Financial Conglomerates | Director/Board Member | |
Laxmi BNS Holdings Ltd.
 Laxmi BNS Holdings Ltd. Drugstore ChainsRetail Trade Founded in 2010, Laxmi BNS Holdings Ltd. is a pharmaceutical distribution and British sales company. The company is based in Ruislip, UK. | Drugstore Chains | Director/Board Member | |
Laxmico Ltd.
 Laxmico Ltd. Medical DistributorsDistribution Services Part of Gowrie Laxmico Ltd., Laxmico is a wholesaler of pharmaceutical products. The company is based in Ruislip, UK. Laxmico was founded in 2009. | Medical Distributors | Director/Board Member | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Generic | Chairman | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Director/Board Member | |
| The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
| University of Cambridge | College/University | Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree | |
| SAREUM HOLDINGS PLC | Miscellaneous | Director/Board Member | |
| The Club Cricket Organisation Ltd. | Director/Board Member | ||
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Ossianix Uk Ltd. | Director/Board Member | ||
| European Molecular Biology Organization | Corporate Officer/Principal | ||
| The Open University | College/University | Doctorate Degree | |
| University of Aberdeen | College/University | Undergraduate Degree | |
| University College London | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 30 |
| Vereinigte Staaten | 13 |
| Südkorea | 5 |
| Deutschland | 3 |
| Dänemark | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 13 |
| Finance | 7 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 40 |
| Corporate Officer/Principal | 9 |
| Independent Dir/Board Member | 7 |
| Chief Executive Officer | 6 |
| Undergraduate Degree | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nilesh Modi
- Unternehmensverbindungen
